Shilajit and mitochondrial function: what the science actually says
Quick answer
Shilajit contains fulvic acid and humic acids that have been studied for roles in electron transport and CoQ10 stabilization, offering a biologically plausible but not yet well-validated mechanism for mitochondrial support. Human trial evidence is limited to small, often industry-funded studies primarily in healthy adults measuring muscle performance outcomes. The video's use of the mitochondrialdisease hashtag is clinically inappropriate, as primary mitochondrial diseases are serious genetic disorders requiring specialist management, not supplement protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @stemcellchristian actually say?
Christian Drupo, who identifies as a stem cell scientist and herbalist, calls shilajit "the number one natural thing that you can take for mitochondrial function." He describes it as compressed biological matter from the Himalayas, composed mainly of fulvic acid and other humic acids. His core argument is that these compounds support electron transport in the mitochondrial energy-production chain. He also shares a personal anecdote: he took shilajit, slept better that same night, and has taken it daily since. He acknowledges that most research documents effects on muscle recovery and strength, but extends the claim to energy production in every cell in the body.
The video has 118K views and uses the hashtag mitochondrialdisease, which is a serious clinical category. That framing deserves scrutiny.
Does the science back this up?
Partially, but with major caveats. There is some legitimate research on shilajit and mitochondrial function, but it is nowhere near strong enough to justify "number one natural" status. The evidence base is thin, mostly preclinical, and often industry-funded.
The most cited human study is Bhagwan et al. (2016, Journal of the International Society of Sports Nutrition), which found shilajit supplementation preserved muscle strength and reduced fatigue in healthy adults over 8 weeks. That is real data, but it is a single small trial. Carrasco-Gallardo et al. (2012, Evidence-Based Complementary and Alternative Medicine) reviewed fulvic acid's role in electron shuttling and CoQ10 stabilization, which is the mechanistic hook Drupo is referencing. The mechanism is plausible. The leap from plausible mechanism to "number one" supplement is not.
A 2019 study by Stohs et al. in the American Journal of Health-System Pharmacy reviewed safety and efficacy and noted that most human trials are small, short, and funded by shilajit suppliers. Animal and in vitro data are more abundant but do not translate cleanly to human supplementation outcomes.
What did they get wrong (or right)?
Credit where it is due: the basic physiology here is accurate. Mitochondria do handle energy production across essentially all cell types, not just one organ. The description of humic and fulvic acids as the active components is consistent with what researchers actually study. And the electron transport angle is a real area of investigation, not invented.
Where Drupo goes wrong is in the confidence of his claims. Calling shilajit "the number one natural" mitochondrial support implies a ranked comparison across all interventions. No such ranking exists in the literature. Regular aerobic exercise, for example, has vastly stronger and more replicated evidence for mitochondrial biogenesis than any supplement, as documented by Yan et al. (2012, Journal of Applied Physiology). Coenzyme Q10 also has a much larger body of human trial data for mitochondrial support.
The hashtag mitochondrialdisease is a real problem. Primary mitochondrial diseases are rare genetic conditions managed by metabolic specialists. Implying shilajit addresses that category is not supported by any clinical evidence and could steer patients away from appropriate care.
His sleep anecdote is not evidence. One night of good sleep after trying a new supplement tells us nothing about mechanism or efficacy.
What should you actually know?
Shilajit is not a scam, but it is not proven to be the best option either. The fulvic acid research is real and ongoing. If you are interested in mitochondrial support, shilajit is a reasonable thing to ask a clinician about, but it sits well below exercise, sleep quality, and established compounds like CoQ10 in terms of evidence strength.
Quality and purity matter enormously here. Shilajit sourced from unregulated suppliers has been found to contain heavy metals including lead and arsenic, as documented in consumer safety analyses. If you use it, source it from third-party tested products.
Anyone with an actual mitochondrial disease diagnosis should not be taking supplement advice from TikTok videos. These conditions require specialist care, genetic counseling, and monitored interventions. The hashtag use in this video is irresponsible regardless of the creator's intentions.
- Shilajit has plausible mechanisms but limited human trial evidence.
- The "number one" claim is not supported by comparative research.
- Heavy metal contamination is a documented risk with low-quality products.
- Mitochondrial disease is a clinical diagnosis, not a wellness category.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Shilajit and mitochondrial function: what the science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Shilajit and mitochondrial function: what the science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Shilajit contains fulvic acid and humic acids that have been studied for roles in electron transport and CoQ10 stabilization, offering a biologically plausible but not yet well-validated mechanism for mitochondrial support.
FormBlends verdict
Shilajit contains fulvic acid and humic acids that have been studied for roles in electron transport and CoQ10 stabilization, offering a biologically plausible but not yet well-validated mechanism for mitochondrial support. Human trial evidence is limited to small, often industry-funded studies primarily in healthy adults measuring muscle performance outcomes. The video's use of the mitochondrialdisease hashtag is clinically inappropriate, as primary mitochondrial diseases are serious genetic disorders requiring specialist management, not supplement protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Shilajit contains fulvic acid and humic acids that have been studied for roles in electron transport and CoQ10 stabilization, offering a biologically plausible but not yet well-validated mechanism for mitochondrial support. Human trial evidence is limited to small, often industry-funded studies primarily in healthy adults measuring muscle performance outcomes. The video's use of the mitochondrialdisease hashtag is clinically inappropriate, as primary mitochondrial diseases are serious genetic disorders requiring specialist management, not supplement protocols.
- 1 small human RCT (Bhagwan et al., 2016) supports shilajit for muscle strength preservation, but no trial has directly compared it to other mitochondrial support interventions.
- Fulvic acid's electron-shuttling mechanism is biologically plausible per Carrasco-Gallardo et al. (2012), but plausibility is not the same as proven clinical benefit in humans.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 1 small human RCT (Bhagwan et al., 2016) supports shilajit for muscle strength preservation, but no trial has directly compared it to other mitochondrial support interventions.
- Fulvic acid's electron-shuttling mechanism is biologically plausible per Carrasco-Gallardo et al. (2012), but plausibility is not the same as proven clinical benefit in humans.
- Aerobic exercise has far more replicated evidence for increasing mitochondrial biogenesis and density than any oral supplement, including shilajit.
- Consumer safety analyses have documented heavy metal contamination including lead and arsenic in unregulated shilajit products, making third-party testing non-negotiable.
- Primary mitochondrial diseases are rare, serious genetic conditions managed by metabolic neurologists. No supplement evidence exists for treating these diagnoses.
- The 'number one natural' framing implies a ranked comparison that does not exist in published literature and overstates the current evidence base significantly.
- Stohs et al. (2019, American Journal of Health-System Pharmacy) noted that most shilajit human trials are small, short, and frequently funded by supplement manufacturers, limiting confidence in results.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Christian Drapeau · TikTok creator
118.1K views on this video
The number one thing you can talke for mitochondrial function #shilajit #mitochondria #mitochondrialdisease #greenscreen
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Christian Drapeau, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.